Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, January 10, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Pharma
International Institute of New England Honors Alnylam CEO Dr. Yvonne Greenstreet With 2026 Golden Door Award
Life Sciences Times
-
January 7, 2026
0
Technology
Fraser Health Cuts Discharge Documentation Time with MEDITECH AI Tool
Life Sciences Times
-
January 7, 2026
0
Venture Capital
Corsera Health Raises $80 Million Series A and Begins First Clinical Trial
Life Sciences Times
-
January 7, 2026
0
Biotech
Ascidian Therapeutics and Forge Biologics Partner to Advance RNA Editing Therapy for Stargardt Disease
Life Sciences Times
-
January 7, 2026
0
Pharma
Kelonia Therapeutics Receives FDA Clearance to Advance KLN-1010 In Vivo CAR-T Therapy for Multiple Myeloma
Life Sciences Times
-
January 7, 2026
0
Venture Capital
Nocion Therapeutics Expands Series B to $93 Million to Advance Late-Stage Development of Taplucainium for Chronic Cough
Life Sciences Times
-
January 7, 2026
0
Technology
VideaHealth Launches AI Leadership Council to Guide Responsible Use of Artificial Intelligence in Dentistry
Life Sciences Times
-
January 7, 2026
0
Venture Capital
Prudentia Sciences Raises $20 Million Series A to Advance AI-Driven Due Diligence in Life Sciences Dealmaking
Life Sciences Times
-
January 7, 2026
0
Pharma
Sarepta Submits Clinical Trial Application for First-in-Human Study of SRP-1005 in Huntington’s Disease
Life Sciences Times
-
January 7, 2026
0
Pharma
Ventus Therapeutics Names VENT-04 as Development Candidate for Inflammatory Diseases
Life Sciences Times
-
January 7, 2026
0
1
2
3
4
...
782
Page 3 of 782
Most Popular
Aurora Therapeutics Launches With $16 Million Seed Round to Scale Personalized Gene Editing for Rare Diseases
January 9, 2026
GC Therapeutics Names Kate Haviland Board Chair, Advances Cell Therapy Pipeline and Platform
January 9, 2026
MEDIPOST Secures $140 Million to Advance U.S. Phase III Stem Cell Trial
January 9, 2026
Prolytix Expands Thrombosis and Hemostasis Testing Capabilities With HRL Assay Acquisition
January 9, 2026
Load more
Recent Comments
Recent Comments